Lynn A. Tetrault - 09 May 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
09 May 2025
Net transactions value
+$56,974
Form type
4
Filing time
09 May 2025, 17:26:57 UTC
Previous filing
11 Sep 2024
Next filing
23 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TETRAULT LYNN A. Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 13 May 2025 0001645512

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $56,974 +7,000 $8.14 7,000 09 May 2025 Lynn Tetrault Rollover IRA
holding NEO Common Stock 61,398 09 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 2,136 09 May 2025 Common Stock 2,136 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 09 May 2025 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 09 May 2025 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 09 May 2025 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 13,882 09 May 2025 Common Stock 13,882 $8.10 Direct
holding NEO Stock Option (Right to Buy) 8,353 09 May 2025 Common Stock 8,353 $14.82 Direct
holding NEO Stock Option (Right to Buy) 8,672 09 May 2025 Common Stock 8,672 $13.71 Direct
holding NEO Restricted Stock Unit 12,254 09 May 2025 Common Stock 12,254 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.